Indeed, effective anti-TNF therapy has been linked to these processes in other chronic inflammatory diseases outside of the gastrointestinal tract, e.g., rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis [58–61], yet this association is less clear in IBD [62]. The gene discussed is TNF; the disease is ankylosing spondylitis.